Format

Send to

Choose Destination
Appl Health Econ Health Policy. 2019 Feb;17(1):55-63. doi: 10.1007/s40258-018-0426-2.

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations.

Author information

1
Asc Academics, Westerhaven 13, 9718 AW, Groningen, The Netherlands. judith@ascacademics.com.
2
Department of Nephrology, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. judith@ascacademics.com.
3
Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
4
Service Apotheek Nederland, De Weegschaal 14, 5215 MN, 's-Hertogenbosch, The Netherlands.
5
Institute for Science in Healthy Aging and healthcaRE (SHARE), University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
6
Department of Health Sciences, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Abstract

OBJECTIVES:

Medication errors that lead to adverse drug reactions are a key cause of unintentional patient harm and subsequent economic burden. To prevent this, measurement of renal function could be considered. The aim of this study was to determine the budget impact of obtaining and evaluating renal function in community pharmacies in the Netherlands to prevent antibiotic-related hospitalizations.

METHODS:

A decision model was built to simulate the process of antibiotic prescriptions in community pharmacies with and without the use of a point-of-care test (PoCT) in patients aged 65 years and older. By using a PoCT, the number of patients with renal function values available increases, leading to the possibility of dose adjustment when necessary. In turn, this might avoid hospitalizations. For this study, real-life patient data were used from 351 community pharmacies. Direct costs of renal function screening, antibiotic treatments, and medical care due to antibiotic-related hospitalization were included.

RESULTS:

The budget impact analysis showed annual cost-savings of €86 per patient through the availability of renal function values in Dutch community pharmacies. Savings were mostly due to avoided hospitalizations.

CONCLUSION:

Obtaining and evaluating renal function in community pharmacies by point of care tests is expected to be cost-saving in the Netherlands.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center